Znanstveni rad - Ostalo
Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms
Diabetology, 4 (2023), 3; 251-258. https://doi.org/10.3390/diabetology4030022


Citirajte ovaj rad

Belančić, A. i Klobučar, S. (2023). Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms. Diabetology, 4. (3), 251-258. doi: 10.3390/diabetology4030022

Belančić, Andrej i Sanja Klobučar. "Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms." Diabetology, vol. 4, br. 3, 2023, str. 251-258. https://doi.org/10.3390/diabetology4030022

Belančić, Andrej i Sanja Klobučar. "Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms." Diabetology 4, br. 3 (2023): 251-258. https://doi.org/10.3390/diabetology4030022

Belančić, A. i Klobučar, S. (2023) 'Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms', Diabetology, 4(3), str. 251-258. doi: 10.3390/diabetology4030022

Belančić A, Klobučar S. Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms. Diabetology [Internet]. 04.07.2023. [pristupljeno 07.07.2024.];4(3):251-258. doi: 10.3390/diabetology4030022

A. Belančić i S. Klobučar, "Sodium-Glucose Co-Transporter 2 Inhibitors as a Powerful Cardioprotective and Renoprotective Tool: Overview of Clinical Trials and Mechanisms", Diabetology, vol. 4, br. 3, str. 251-258, Srpanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:874312. [Citirano: 07.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.